Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) CEO Sells 168,800 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CEO Jeff Shaner sold 168,800 shares of the stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $7.38, for a total value of $1,245,744.00. Following the transaction, the chief executive officer directly owned 2,824,117 shares in the company, valued at $20,841,983.46. The trade was a 5.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Jeff Shaner also recently made the following trade(s):

• On Thursday, February 19th, Jeff Shaner sold 173,225 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.21, for a total value of $1,248,952.25.
• On Tuesday, February 17th, Jeff Shaner sold 119,884 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.65, for a total value of $917,112.60.
• On Friday, January 2nd, Jeff Shaner sold 29,357 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.85, for a total value of $230,452.45.
• On Wednesday, December 31st, Jeff Shaner sold 27,674 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.18, for a total value of $226,373.32.
• On Tuesday, December 30th, Jeff Shaner sold 27,929 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.36, for a total value of $233,486.44.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH traded up $0.02 during midday trading on Thursday, hitting $7.42. 3,877,110 shares of the company’s stock traded hands, compared to its average volume of 938,081. The firm has a fifty day moving average of $8.48 and a 200 day moving average of $8.44. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.67 and a 1 year high of $10.32. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. The stock has a market capitalization of $1.55 billion, a price-to-earnings ratio of 20.61 and a beta of 2.06.

Institutional Investors Weigh In On Aveanna Healthcare

A number of institutional investors have recently bought and sold shares of AVAH. AQR Capital Management LLC increased its stake in Aveanna Healthcare by 21.2% in the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock worth $142,000 after buying an additional 4,602 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Aveanna Healthcare by 8.3% in the first quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock worth $1,842,000 after acquiring an additional 25,974 shares during the period. Jane Street Group LLC boosted its stake in shares of Aveanna Healthcare by 522.0% in the first quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock worth $407,000 after acquiring an additional 63,010 shares during the period. MQS Management LLC purchased a new stake in shares of Aveanna Healthcare during the second quarter worth about $59,000. Finally, Belvedere Trading LLC bought a new stake in Aveanna Healthcare during the 2nd quarter valued at approximately $62,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Royal Bank Of Canada lifted their price target on shares of Aveanna Healthcare from $10.00 to $11.00 and gave the stock a “sector perform” rating in a research note on Thursday, January 15th. Jefferies Financial Group raised their target price on Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a report on Tuesday, October 28th. Barclays lifted their target price on Aveanna Healthcare from $9.00 to $11.00 and gave the company an “overweight” rating in a research report on Friday, January 16th. BMO Capital Markets began coverage on Aveanna Healthcare in a research report on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price target for the company. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $13.00 price objective on shares of Aveanna Healthcare in a research report on Friday, December 5th. Five research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, Aveanna Healthcare presently has a consensus rating of “Hold” and a consensus target price of $11.06.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.